All In Biotech

Drug Trial Radar · NCT00407082

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants

A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety & Efficacy of Intravitreal Fluocinolone Acetonide (0.59 or 2.1 mg) Implant in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

Last checked: Nov 19, 2026Latest source record: Dec 8, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 278 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

278

Actual

Start

Dec 2000

Primary completion

Sep 2005

Study completion Sep 2005

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedIndustry
Sponsor type
Industry
First posted
Dec 4, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.

Conditions

  • Noninfectious Posterior Uveitis

Interventions

  • fluocinolone acetonide intravitreal implantDrug

    Fluocinolone acetonide ocular implant 0.59mg

  • Fluocinolone acetonide 2.1mgDrug

    Fluocinolone acetonide ocular implant 2.1mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recurrence of uveitis before and after implantation.Time frame: 34 weeks pre-implantation; 34 weeks, 1 year, 2 years and 3 years post-implantation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Duke Eye Center

    Durham, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.